Table 2.
The mediation effect of gut microbiota on pancreatic cancer via affecting serum metabolites.
| Exposure | Mediation | Outcome | β (EM) | β (MO) | β (EO) | Indirect effect | Direct effect | Direct effect OR (95% CI) |
|---|---|---|---|---|---|---|---|---|
| Pauljensenia sp000411416 | Octanoylcarnitine (c8) | Pancreatic cancer | −0.175 | −0.098 | 0.263 | 0.017 | 0.246 | 1.0172 (0.9945, 1.0404) |
| Pauljensenia sp000411417 | Glutarylcarnitine (C5-DC) | Pancreatic cancer | −0.155 | −0.094 | 0.263 | 0.015 | 0.249 | 1.0146 (0.9957, 1.0340) |
β (EM): coefficient from exposure to mediator; β (MO): coefficient from mediator to outcome; β (EO): coefficient from exposure to outcome (total effect). Indirect effect: product of β (EM) and β (MO). Direct effect: total effect minus indirect effect; OR (95% CI): odds ratio for direct effect with 95% confidence interval. All estimates were derived using inverse variance-weighted Mendelian randomization.